Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Mixed Dementias 1Lymphoma, Follicular 1Alzheimer Disease 1

Interventions

Dexamethasone 4Methods 2Electroencephalography 2selinexor 1pomalidomide 1ixazomib 1Transurethral Resection of Bladder 1Telemedicine 1Tablets 1Surgical Procedures, Operative 1Standard of Care 1Neurofeedback 1Melphalan 1Mass Screening 1Magnetic Resonance Imaging 1Lysine Acetyltransferase 5 1Hypnosis 1Hormones 1Exercise 1Ethanol 1Drug Delivery Systems 1Cyclophosphamide 1Control Groups 1Cholinesterase Inhibitors 1Calcium Dobesilate 1Bortezomib 1Biopsy 1Amyloid 1Amputation, Surgical 17-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Alzheimer Disease × Cholinesterase Inhibitors × Clear all
NCT02187276 2014-09-12

The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed Dementia

Federal University of Minas Gerais

Completed
129 enrolled
Lymphoid

Mixed Dementias, Alzheimer Disease, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡